These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2864878)

  • 1. Vecuronium in the myasthenic patient.
    Hunter JM; Bell CF; Florence AM; Jones RS; Utting JE
    Anaesthesia; 1985 Sep; 40(9):848-53. PubMed ID: 2864878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Edrophonium and neostigmine for reversal of the neuromuscular blocking effect of vecuronium.
    Engbaek J; Ording H; Ostergaard D; Viby-Mogensen J
    Acta Anaesthesiol Scand; 1985 Jul; 29(5):544-6. PubMed ID: 2863917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response relationships and neuromuscular blocking effects of vecuronium pancuronium during ketamine anaesthesia.
    Engbaek J; Ording H; Pedersen T; Viby-Mogensen J
    Br J Anaesth; 1984 Sep; 56(9):953-7. PubMed ID: 6147154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular blocking effects of vecuronium and pancuronium during halothane anaesthesia.
    Engbaek J; Ording H; Viby-Mogensen J
    Br J Anaesth; 1983 Jun; 55(6):497-500. PubMed ID: 6134535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vecuronium in the myasthenic patient.
    Eisenkraft JB; Sawhney RK; Papatestas AE
    Anaesthesia; 1986 Jun; 41(6):666-7. PubMed ID: 2873757
    [No Abstract]   [Full Text] [Related]  

  • 6. Recovery times following edrophonium and neostigmine reversal of pancuronium, atracurium, and vecuronium steady-state infusions.
    Kopman AF
    Anesthesiology; 1986 Dec; 65(6):572-8. PubMed ID: 2878631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of org NC 45 (vecuronium) and pancuronium neuromuscular blockade by neostigmine.
    Gencarelli PJ; Miller RD
    Br J Anaesth; 1982 Jan; 54(1):53-6. PubMed ID: 6119998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between the continuous infusion of vecuronium and the intermittent administration of pancuronium and vecuronium.
    Noeldge G; Hinsken H; Buzello W
    Br J Anaesth; 1984 May; 56(5):473-7. PubMed ID: 6144316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical studies on Org NC 45: comparison with pancuronium.
    Kerr WJ; Baird WL
    Br J Anaesth; 1982 Nov; 54(11):1159-65. PubMed ID: 6128012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromuscular blocking action of vecuronium in the dog and its reversal by neostigmine.
    Jones RS
    Res Vet Sci; 1985 Mar; 38(2):193-6. PubMed ID: 2860709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vecuronium bromide in anaesthesia for laparoscopic sterilization.
    Caldwell JE; Braidwood JM; Simpson DS
    Br J Anaesth; 1985 Aug; 57(8):765-9. PubMed ID: 2861837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atracurium in the myasthenic patient.
    Bell CF; Florence AM; Hunter JM; Jones RS; Utting JE
    Anaesthesia; 1984 Oct; 39(10):961-8. PubMed ID: 6093617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between pancuronium bromide and vecuronium bromide.
    Rashkovsky OM; Agoston S; Ket JM
    Br J Anaesth; 1985 Nov; 57(11):1063-6. PubMed ID: 2864945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of pancuronium. Neuromuscular and cardiovascular effects of a mixture of neostigmine and glycopyrronium.
    Goldhill DR; Embree PB; Ali HH; Savarese JJ
    Anaesthesia; 1988 Jun; 43(6):443-6. PubMed ID: 3407868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacology of ORG NC45 (NorcuronTM): a new nondepolarizing muscle relaxant.
    Fahey MR; Morris RB; Miller RD; Sohn YJ; Cronnelly R; Gencarelli P
    Anesthesiology; 1981 Jul; 55(1):6-11. PubMed ID: 6113794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myasthenia gravis and pipecuronium--report of two cases.
    Naguib M; Sari-Kouzel A; Ashour M; Seraj M; Messahel F
    Middle East J Anaesthesiol; 1992 Feb; 11(4):381-90. PubMed ID: 1320731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromuscular blocking effects of atracurium, vecuronium and pancuronium during bolus and infusion administration.
    Gramstad L; Lilleaasen P
    Br J Anaesth; 1985 Nov; 57(11):1052-9. PubMed ID: 2864943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of different doses of vecuronium in patients with liver dysfunction.
    Hunter JM; Parker CJ; Bell CF; Jones RS; Utting JE
    Br J Anaesth; 1985 Aug; 57(8):758-64. PubMed ID: 2861836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of Org NC 45 neuromuscular blockade by neostigmine, pyridostigmine, and 4-aminopyridine.
    Booij LH; van der Pol F; Crul JF; Miller RD
    Anesth Analg; 1980 Jan; 59(1):31-4. PubMed ID: 7188663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium.
    Ali HH; Savarese JJ; Basta SJ; Sunder N; Gionfriddo M
    Br J Anaesth; 1983; 55 Suppl 1():107S-111S. PubMed ID: 6134539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.